Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of doxycycline foam to prevent EGFR inhibitor–associated rash in cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis [NA]
Clinical trial update for Calcium-41 chloride aqueous solution in diagnosing prostate cancer with bone metastasis; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2017-12-20Clinical Trial Update: Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating fluorescein for lymphatic mapping and sentinel lymph node biopsy in patients with stage I-II malignant…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Engagement of Patients With Advanced Cancer [NA]
Clinical trial update noting engagement of patients with advanced cancer; status completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies [Phase 1]
Phase 1 trial evaluating safety and tolerability of olaparib tablets in Japanese patients with advanced solid malignancies has completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors [Phase 1]
Phase I study evaluating the combination of etanercept with weekly docetaxel in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Iron Overload in Patients Undergoing Donor Stem Cell Transplant
This clinical trial status update reports completion of a study examining iron overload in patients undergoing donor hematopoietic stem cell…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Vaccination With Tetanus and KLH to Assess Immune Responses.
A terminated clinical trial evaluated immune responses to a vaccine consisting of tetanus toxoid and KLH in cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites [Phase 2]
Phase 2 trial of mitomycin delivered via hyperthermic peritoneal perfusion for malignant ascites due to metastatic cancer, terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies [Phase 1]
Phase 1 study of Salinosporamide A (NPI-0052) in patients with advanced cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: A Dose-escalation Study in Subjects With Advanced Malignancies [Phase 1]
A Phase 1 dose-escalation study in patients with advanced malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects [Phase 1]
A Phase 1 study evaluating ABT-263 (navitoclax) with erlotinib, ABT-263 with irinotecan, and ABT-263 monotherapy in cancer patients has comp…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Topotecan Pharmacokinetic Characterization Study [Phase 1]
Completed Phase 1 pharmacokinetic characterization study of topotecan sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies [Phase 1, Phase 2]
Phase I/II study evaluating decitabine in combination with genistein for pediatric relapsed or refractory cancers has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Cyclophosphamide Drug Interaction Study In Cancer Patients [Phase 1]
Phase 1 trial evaluating drug interactions with cyclophosphamide in cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment [NA]
This status update reports on a completed clinical trial evaluating sensory properties of oral nutrition supplements in patients at risk for…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors [Phase 1]
This Phase 1 pharmacokinetic study evaluated how coadministration of rabeprazole and rifampin affects dabrafenib exposure in patients with B…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor [Phase 1]
This completed Phase 1 open-label study assessed how a high-fat meal and drug particle size influence the pharmacokinetics of GSK2118436 (da…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) [Phase 3]
Phase 3 trial comparing Bepanthen against Cetomacrogol for EGFR inhibitor–related skin rash in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors [Phase 1]
Phase 1 trial evaluating the effect of repeat oral dosing of GSK2118436 on cardiac repolarization in subjects with V600 BRAF mutation-positi…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation [Phase 1]
Phase 1 trial evaluating the relative bioavailability of a pediatric powder-for-suspension formulation (PfOS); the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib [Phase 1]
This Phase 1 trial evaluated the bioavailability and the effect of food on two formulations of Afuresertib in cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors [Phase 1]
Phase 1 pharmacokinetic studies evaluated how GSK2118436 (Dabrafenib) interacts with warfarin and how ketoconazole and gemfibrozil affect GS…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Safety, Pharmacokinetics (PK) of AKT and MEK Combination [Phase 1]
This Phase 1 trial reports safety and pharmacokinetic data for a combination of an AKT inhibitor and a MEK inhibitor in cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study evaluating bioavailability and the effect of food on the original gelatin formulation and two new formulations…